Officer exercised or converted 3,054 BDX derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jan 15, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jan 16, 2026
OfficerOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001944816-26-000002
Filed / recordedJan 16, 2026, 8:43 PM UTCAdded to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly IssuerBECTON DICKINSON & CO Reporting personMichael David Garrison Officer titleEVP & Pres Med.Essntl&BioPharm SecurityStock Appreciation Rights TableDerivative (Table II) Transaction dateJan 15, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- The stock appreciation rights vested in four annual installments beginning one year from the grant date.
Around the same time
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.